Stay updated on Adagrasib Combo in CRC Clinical Trial
Sign up to get notified when there's something new on the Adagrasib Combo in CRC Clinical Trial page.

Latest updates to the Adagrasib Combo in CRC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe status of the Phase I Trial of Adagrasib (MRTX849) has changed from 'Recruiting' to 'Active, not recruiting', and the trial's expected completion date has been updated from December 9, 2024, to March 10, 2025.SummaryDifference2%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference5%
- Check37 days agoChange DetectedThe webpage now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check44 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check58 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check66 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.SummaryDifference1.0%
Stay in the know with updates to Adagrasib Combo in CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib Combo in CRC Clinical Trial page.